Stand Up To Cancer, Jazz Pharmaceuticals Collaborate to Accelerate Drug Development
October 20th 2021In an interview with Pharmacy Times®, Lee Helman, MD, vice chair on Stand Up To Cancer's Scientific Advisory Committee, discusses the research collaboration between Stand Up To Cancer and Jazz Pharmaceuticals.
Watch
Social Media Campaign Aims to Raise Awareness, Create Change for Pharmacy Working Conditions
October 19th 2021The #PizzaIsNotWorking campaign originated because free pizza or other mundane incentives do not adequately address the unrealistic expectations in pharmacies, which lead to an emphasis on metrics rather than patient safety.
Watch
TAK1-Inhibitors Offer Potential Treatment Strategy for Patients With Multiple Myeloma
October 19th 2021TAK1 restricts receptor-interacting serine/threonine-protein kinase 1 dependent cell death, and targeting TAK1 with inhibitors shifts cells from pro-survival programs to cell death, according to the study.
Read More
Expert: MDMA for the Treatment of PTSD May Be FDA-Approved by the End of 2023
October 19th 2021Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses what MAPS is, and how MAPS is engaged with the field of psychedelic medicine and its use in health care.
Watch